Compass Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company focuses on the development of psilocybin therapy through late-stage clinical trials, aiming to create a new standard in the treatment of mental health conditions such as treatment-resistant depression.

We are COMPASS Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Our first clinical development programme is researching investigational COMP360 psilocybin treatment for patients with treatment-resistant depression. 

We want to transform the patient experience in mental health care. 

WPSS.bio

Vivo Capital

Logos Capital

Aisling Capital

Armistice Capital

Soleus Capital

Surveyor Capital

TCG Crossover

Paradigm BioCapital Advisors

PFM Health Sciences

RA Capital Management

Principia SGR

Camden Partners

Founders Fund

McQuade Center for Strategic Research and Development

Able Partners

ATAI Life Sciences

Skyviews Life Science

Perceptive Advisors

Justin Mateen

Compass Pathways

COM:COMPASSPATHWAYS

Compass Pathways

Analysis Not Available